Genome Valley

Genome Valley is an Indian high-technology business district spread across 2000 acre/(3.1 sq mi) in Hyderabad, India. It is located across the suburbs, Turakapally, Shamirpet, Medchal, Uppal, Patancheru, Jeedimetla, Gachibowli and Keesara. The Genome Valley has developed as a cluster for Biomedical research, training and manufacturing. Genome Valley is now into its Phase III, which is about 11 kms from the Phase I and II with the total area approximately 2000 acre.

History
Genome Valley was commissioned by the then combined Government Andhra Pradesh in 1999 as S. P. Biotech Park in a public-private partnership with Bharat Biotech International, and its founder Krishna Ella, alongside private infrastructure companies such as Shapoorji Pallonji Group and ICICI Bank.

Alexandria Knowledge Park SEZ
In 2009, U.S.-based infrastructure giant Alexandria Real Estate Equities has announced its plans to invest in the bio-cluster, which led to the Alexandria Knowledge Park SEZ. The bio-cluster at Shamirpet holds Certification mark by the United States Patent and Trademark Office and the European Union.

IKP Knowledge Park
The IKP Knowledge Park is spread over 200 acres in Turakapally, is an initiative of ICICI Bank with five "innovation corridors" - a first of its kind knowledge-nurturing centre for Indian companies and a knowledge gateway for multinational companies". The first phase of Innovation Corridor I, comprising 10 laboratories, around 3,000 ft² (300 m²) each, is operational and fully occupied. The second phase of Innovation Corridor I, comprising 16 laboratory modules of 1,700 ft² (170 m²) each, is ready for operation.

MN Park
In 2016, Mission Neutral Park has acquired specialized R&D assets in Genome Valley from U.S.-based Alexandria REIT and rechristened it as MN Park. It is a collaborative life sciences ecosystem in Genome Valley, Hyderabad consisting of Grade A R&D facilities.

MN Park is spread over 400 acres including build-up facilities of around 600,000 sq.ft. provided to global tenants like Novartis, GlaxoSmithKline, Mylan and Ashland Inc. MN’s focus area: Preleased industrial assets and specialized office spaces to sectors including specialized warehousing, logistics, food processing, light manufacturing, pharmaceutical R&D, biotechnology, etc.